Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 66.67%-270K | -109.12%-154K | 208.58%1.14M | 101.87%204K | -69.84%374K | 85.54%-810K | -61.28%1.69M | 90.40%-1.05M | -228.49%-10.93M | 117.67%1.24M |
| Net profit before non-cash adjustment | -1,067.89%-1.06M | -60.14%57K | 105.77%93K | 88.67%-1.19M | -76.01%166K | 102.68%109K | -95.77%143K | 84.71%-1.61M | 69.96%-10.53M | 101.30%692K |
| Total adjustment of non-cash items | 8.10%347K | 17.15%362K | 6.75%332K | 71.05%1.34M | -34.75%400K | 227.89%321K | 185.36%309K | -60.33%311K | -98.27%784K | -98.55%613K |
| -Depreciation and amortization | 28.89%348K | 34.81%364K | 24.07%335K | 93.23%1.03M | -57.59%218K | 202.27%270K | 208.00%270K | -49.25%270K | 15.65%532K | 196.25%514K |
| -Reversal of impairment losses recognized in profit and loss | --0 | --0 | --0 | --205K | ---- | ---- | ---- | ---- | --0 | --0 |
| -Assets reserve and write-off | ---- | ---- | ---- | -193.75%-30K | ---30K | --0 | --0 | --0 | --32K | ---- |
| -Disposal profit | --0 | --0 | --0 | --7K | ---- | ---- | ---- | ---- | --0 | --0 |
| -Other non-cash items | -101.96%-1K | -105.13%-2K | -107.32%-3K | -40.45%131K | --0 | 750.00%51K | 153.42%39K | -81.36%41K | -99.45%220K | -99.82%67K |
| Changes in working capital | 135.32%438K | -146.32%-573K | 184.46%714K | 104.75%56K | -195.38%-192K | 3.05%-1.24M | -7.96%1.24M | 121.31%251K | 35.84%-1.18M | -101.73%-65K |
| -Change in receivables | -101.66%-18K | 1,071.43%204K | 127.54%179K | 219.39%591K | -93.35%180K | 212.94%1.08M | 98.80%-21K | -31.31%-650K | -117.88%-495K | -94.54%2.71M |
| -Change in payables | 119.64%456K | -161.76%-777K | -40.62%535K | 21.67%-535K | 86.57%-372K | -623.36%-2.32M | -59.30%1.26M | 231.92%901K | 78.56%-683K | 94.14%-2.77M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | 105.26%1K | -97.06%2K | -95.95%3K | -43.32%123K | 0 | -116.96%-19K | 141.72%68K | -65.90%74K | -77.49%217K | -89.44%51K |
| Tax refund paid | -6,250.00%-127K | 0 | 0 | -500.00%-8K | 0 | -122.22%-2K | 57.14%-3K | -250.00%-3K | 100.10%2K | -100.14%-2K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 52.35%-396K | -108.67%-152K | 216.77%1.14M | 102.98%319K | -70.99%374K | 84.84%-831K | -58.15%1.75M | 90.87%-978K | -242.30%-10.71M | 125.49%1.29M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | --0 | ---98K | --0 | 122.86%24K | 318.18%24K | --0 | --0 | --0 | -133.33%-105K | -222.22%-11K |
| Net intangibles purchase and sale | --0 | 14.67%-1.02M | --0 | 39.87%-2.06M | 74.72%-867K | --0 | -139.18%-1.19M | --0 | -2.54%-3.43M | -150.55%-3.43M |
| Net changes in other investments | --0 | ---- | ---- | -63.38%512K | ---- | ---- | ---- | ---- | --1.4M | ---- |
| Investing cash flow | --0 | 8.80%-1.09M | --0 | 28.55%-1.52M | 83.80%-331K | --0 | -170.68%-1.19M | --0 | 93.24%-2.13M | 86.84%-2.04M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | --0 | --0 | --0 | ---8M | --0 | ---- | ---- | ---- | --0 | ---- |
| Net common stock issuance | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --10.29M | --0 |
| Interest paid (cash flow from financing activities) | --0 | --0 | --0 | 41.88%-254K | --0 | 72.88%-32K | -145.34%-107K | 73.68%-115K | -17.16%-437K | 68.36%-118K |
| Net other fund-raising expenses | ---- | ---- | ---- | 34,656.52%7.99M | -127.27%-6K | ---- | ---- | -200.00%-23K | 176.67%23K | --22K |
| Financing cash flow | --0 | --0 | --0 | -102.63%-260K | 93.75%-6K | 68.93%-32K | -142.21%-84K | -101.40%-138K | 2,550.87%9.88M | 76.18%-96K |
| Net cash flow | ||||||||||
| Beginning cash position | -88.59%-1.97M | 52.17%-727K | -362.62%-1.87M | -115.78%-404K | -527.35%-1.91M | -118.39%-1.04M | -276.24%-1.52M | -115.78%-404K | -90.51%2.56M | -96.08%446K |
| Current changes in cash | 54.11%-396K | -359.96%-1.24M | 202.33%1.14M | 50.57%-1.47M | 104.35%37K | 83.49%-863K | -92.15%477K | 62.35%-1.12M | 87.86%-2.96M | 95.95%-850K |
| End cash Position | -23.98%-2.36M | -88.59%-1.97M | 52.17%-727K | -362.62%-1.87M | -362.62%-1.87M | -527.35%-1.91M | -118.39%-1.04M | -276.24%-1.52M | -115.78%-404K | -115.78%-404K |
| Free cash flow | 52.35%-396K | -326.02%-1.27M | 216.77%1.14M | 87.77%-1.74M | 77.05%-493K | 83.80%-831K | -92.29%561K | 93.13%-978K | -444.02%-14.24M | 66.53%-2.15M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.